None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Gender: Non-pregnant, non-lactating female aged between 40 to 60. 2) Subjects willing to give written informed consent 3) Women of childbearing potential must have a negative urine pregnancy test before study entry. 4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant, breastfeeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3. Have open sores or open lesions in the treatment area(s). 4. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 5. Have participated in any interventional clinical trial in the previous 30 days. 6.Have a known sensitivity to any of the constituents of the test product 7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 8. Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Skin moisturization, Elasticity, Melanin content, Lightness, Firmness, TEWLTimepoint: Day0, Day15 and Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety and tolerabilityTimepoint: Day0, and Day28 | — |
Countries
India
Contacts
CCFT Laboratories